SLN silence-therapeutics.com: Sof marja

silence-therapeutics.com (SLN) - korporativ logo

Silence Therapeutics global kardiologiya sherikliklari orqali yagona texnologiya risklarini kamaytirib, o'z loyihalar portfelini barqarorlashtirmoqda. Tarixiy savdo marjalari moliyaviy dinamikani namoyish etadi, bunda -11289.60 ushbu parametrning qiymatini ko'rsatadi. Biznes yopiq innovatsiya zanjirini yaratuvchi o'zining maxsus GalNAc tizimiga hamda yurak-qon tomir patologiyalarini davolash uchun jigarga yuqori aniqlikda yo'naltirilgan texnologiyaga tayanadi.

silence-therapeutics.com (SLN) - Sof marja 21.06.2023dan 20.11.2026gacha

Silence Therapeutics Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (SLN)

- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Silence Therapeutics PLC - SLN
Silence Therapeutics PLC tayyor mahsulotlari

Himoyaviy portfelni shakllantirish uchun fundamental skrining sof marjaning tahlilini talab qiladi, bu esa daromadning har bir rublida yakuniy foydaning ulushini belgilab, biznesning umumiy operatsion samaradorligini aks ettiradi. Yurak-qon tomir patologiyalarini davolash uchun RNK dori vositalarini ishlab chiquvchi Silence Therapeutics (SLN) uchun yuklamalardan olinadigan sof foyda marjasi yuqori texnologik platformaning ilmiy tadqiqotlarni haqiqiy moliyaviy natijalarga aylantirish qobiliyatining ko'rsatkichi bo'lib xizmat qiladi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX